<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04665011</url>
  </required_header>
  <id_info>
    <org_study_id>PROT 000054</org_study_id>
    <nct_id>NCT04665011</nct_id>
  </id_info>
  <brief_title>Validation of Indicor Photoplethysmography (PPG) Valsalva Pulse Response vs Non-invasive Blood Pressure</brief_title>
  <official_title>Validation of Indicor Photoplethysmography (PPG) Valsalva Pulse Response vs Non-invasive Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vixiar Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vixiar Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study designed is compare the pulse response to the Valsalva maneuver between a&#xD;
      photoplethysmography sensor (PPG) and non-invasive blood pressure sensor for the purpose of&#xD;
      validating the PPG methodology in deriving a value for the Valsalva pulse response. The aim&#xD;
      is to show that the PPG method captures the same phase responses as the blood pressure&#xD;
      monitor and the primary outcome is the correlation between pulse amplitude ratios for the&#xD;
      pulse at the end of the Valsalva to an average baseline pulse.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With both a photoplethysmography (PPG; Indicor, Vixiar Medical,. Baltimore, MD) and&#xD;
      non-invasive blood pressure (Caretaker, Caretaker Medical, Charlottesville, VA) sensors in&#xD;
      place on the index and middle fingers, respectively, each patient will be asked to perform&#xD;
      three mild, 10-sec Valsalva maneuvers with at least 45 seconds between. Pulse recordings will&#xD;
      be collected from each device to compare phases of the Valsalva pulse response including&#xD;
      pulse amplitude changes and baseline movement. The primary outcome is the correlation between&#xD;
      pulse amplitude ratios for the pulse at the end of the Valsalva to an average baseline pulse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 14, 2020</start_date>
  <completion_date type="Actual">January 28, 2021</completion_date>
  <primary_completion_date type="Actual">January 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pulse amplitude ratio</measure>
    <time_frame>5 minutes</time_frame>
    <description>The correlation between PPG-based and non-invasive blood pressure pulse amplitude ratio during a Valsalva maneuver.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phases of valsalva pulse response</measure>
    <time_frame>5 minuntes</time_frame>
    <description>The agreement between PPG-based and non-invasive blood pressure pulse tracings during a Valsalva maneuver.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">121</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Clinically stable adults, including heart failure patients visiting an outpatient clinic</arm_group_label>
    <description>Observational to compare simultaneous pulse tracings from PPG and non-invasive blood pressure monitors in capturing the pulse responses to a Valsalva maneuver.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indicor</intervention_name>
    <description>A simple, non-invasive tool to report pulse response to a Valsalva maneuver</description>
    <arm_group_label>Clinically stable adults, including heart failure patients visiting an outpatient clinic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Caretaker</intervention_name>
    <description>non-invasive blood pressure monitor</description>
    <arm_group_label>Clinically stable adults, including heart failure patients visiting an outpatient clinic</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study sample has a focus on heart failure patients as this is a clinical target&#xD;
        population for the clinical use of the Indicor. However, non-heart failure subjects may be&#xD;
        needed to ensure that a range of normal outcome values are included in the analysis.&#xD;
        Therefore, at least 70% of the enrollment is intended to be derived from a cardiology&#xD;
        practice office, and up to 30% of the enrollment may be non-patient participants.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically stable adults, including heart failure patients visiting an outpatient&#xD;
             clinic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Atrial flutter or atrial fibrillation with an irregular ventricular response&#xD;
&#xD;
          -  Significant atrial or ventricular ectopy&#xD;
&#xD;
          -  History of paradoxical emboli&#xD;
&#xD;
          -  Hypertrophic obstructive cardiomyopathy&#xD;
&#xD;
          -  Known intracardiac shunt&#xD;
&#xD;
          -  Known severe aortic valve stenosis&#xD;
&#xD;
          -  Known severe mitral valve stenosis&#xD;
&#xD;
          -  History of embolic CVA&#xD;
&#xD;
          -  Myocardial infarction within one week of intended Indicor testing&#xD;
&#xD;
          -  Uncontrolled hypertension (systolic BP &gt;160mmHg or diastolic BP&gt;100mmHg)&#xD;
&#xD;
          -  Hypotension (systolic BP &lt;90mmHg)&#xD;
&#xD;
          -  Symptomatic bradycardia&#xD;
&#xD;
          -  Known cholesterol emboli&#xD;
&#xD;
          -  Poor left ventricular function with left ventricular thrombus&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Significant aortic valvular disease&#xD;
&#xD;
          -  Patients weighing less than 40kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith H. Newby, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fort Norfolk Cardiology Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fort Norfolk Cardiology Associates</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

